Anthracycline metabolism and toxicity in human myocardium: Comparisons between doxorubicin, epirubicin, and a novel disaccharide analogue with a reduced level of formation and [4Fe-4S] reactivity of its secondary alcohol metabolite

被引:52
作者
Minotti, G
Licata, S
Saponiero, A
Menna, P
Calafiore, AM
Di Giammarco, G
Liberi, G
Animati, F
Cipollone, A
Manzini, S
Maggi, CA
机构
[1] Univ G DAnnunzio, Sch Pharm, Dept Drug Sci, I-66013 Chieti, Italy
[2] Univ G DAnnunzio, Sch Med, Dept Cardiac Surg, I-66013 Chieti, Italy
[3] Univ Cattolica Sacro Cuore, Inst Pharmacol, Rome, Italy
[4] Menarini Ric SPA, Rome, Italy
关键词
D O I
10.1021/tx000143z
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Secondary alcohol metabolites have been proposed to mediate chronic cardiotoxicity induced by doxorubicin (DOX) and other anticancer anthracyclines. in this study, NADPH-supplement-ed human cardiac cytosol was found to reduce the carbonyl group in the side chain of the tetracyclic ring of DOX, producing the secondary alcohol metabolite doxorubicinol (DOXol). A decrease in the level of alcohol metabolite formation was observed by replacing DOX with epirubicin (EPI), a less cardiotoxic analogue characterized by an axial-to-equatorial epimerization of the hydroxyl group at C-4 in the amino sugar bound to the tetracyclic ring (daunosamine). A similar decrease was observed by replacing DOX with MEN 10755, a novel anthracycline with preclinical evidence of reduced cardiotoxicity. MEN 10755 is characterized by the lack of a methoxy group at C-4 in the tetracyclic ring and by intercalation of 2,6-dideoxy-L-fucose between daunosamine and the aglycone. Multiple comparisons with methoxy- or 4-demethoxyaglycones, and a number of mono- or disaccharide 4-demethoxyanthracyclines, showed that both the lack of the methoxy group and the presence of a disaccharide moiety limited alcohol metabolite formation by MEN 10755. Studies with enzymatically generated or purified anthracycline secondary alcohols also showed that the presence of a disaccharide moiety, but not the lack of a methoxy group, made the metabolite of MEN 10755 less reactive with the [4Fe-4S] cluster of cytoplasmic aconitase, as evidenced by its limited reoxidation to the parent carbonyl anthracycline and by a reduced level of delocalization of Fe(II) from the cluster. Collectively, these studies (i) characterize the different influence of methoxy and sugar substituents on the formation and [4Fe-4S] reactivity of anthracycline secondary alcohols, (ii) lend support to the role of alcohol metabolites in anthracycline-induced cardiotoxicity, as they demonstrate that the less cardiotoxic EPI and;MEN 10755 share a reduction in the level of formation of such metabolites, and (iii) suggest that the cardiotoxicity of MEN 10755 might be further decreased by the reduced [4Fe-4S] reactivity of its alcohol metabolite.
引用
收藏
页码:1336 / 1341
页数:6
相关论文
共 22 条
  • [1] Doxorubicin disaccharide analogue: Apoptosis-related improvement of efficacy in vivo
    Arcamone, F
    Animati, F
    Berettoni, M
    Bigioni, M
    Capranico, G
    Casazza, AM
    Caserini, C
    Cipollone, A
    DeCesare, M
    Franciotti, M
    Lombardi, P
    Madami, A
    Manzini, S
    Monteagudo, E
    Polizzi, D
    Pratesi, G
    Righetti, SC
    Salvatore, C
    Supino, R
    Zunino, F
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (16) : 1217 - 1223
  • [2] AUST S D, 1985, Journal of Free Radicals in Biology and Medicine, V1, P3, DOI 10.1016/0748-5514(85)90025-X
  • [3] Development of daunorubicin resistance in tumour cells by induction of carbonyl reduction
    Ax, W
    Soldan, M
    Koch, L
    Maser, E
    [J]. BIOCHEMICAL PHARMACOLOGY, 2000, 59 (03) : 293 - 300
  • [4] Inhibition of aldo-keto reductases by phenobarbital alters metabolism, pharmacokinetics and toxicity of doxorubicin in rats
    Behnia, K
    Boroujerdi, M
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1999, 51 (11) : 1275 - 1282
  • [5] Comparison of doxorubicin- and MEN 10755-induced long-term progressive cardiotoxicity in the rat
    Cirillo, R
    Sacco, G
    Venturella, S
    Brightwell, J
    Giachetti, A
    Manzini, S
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 35 (01) : 100 - 108
  • [6] GELVAN D, 1988, CANCER RES, V48, P5645
  • [7] Human pharmacokinetic characterization and in vitro study of the interaction between doxorubicin and paclitaxel in patients with breast cancer
    Gianni, L
    Vigano, L
    Locatelli, A
    Capri, G
    Giani, A
    Tarenzi, E
    Bonadonna, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) : 1906 - 1915
  • [8] GONZALEZ B, 1995, CANCER RES, V55, P4646
  • [9] Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress
    Hentze, MW
    Kuhn, LC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (16) : 8175 - 8182
  • [10] ANTHRACYCLINES AND THEIR C-13 ALCOHOL METABOLITES - GROWTH-INHIBITION AND DNA DAMAGE FOLLOWING INCUBATION WITH HUMAN TUMOR-CELLS IN CULTURE
    KUFFEL, MJ
    REID, JM
    AMES, MM
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 30 (01) : 51 - 57